Advanced Pancreatic Ductal Adenocarcinoma
11 clinical trials · Condition
◉ Watch Advanced Pancreatic Ductal Adenocarcinoma
| Record | Firm | Date |
|---|---|---|
| KN046 in Subjects With Advanced Pancreatic Ductal Adenocarcinoma. (NCT05149326) | Jiangsu Alphamab Biopharmaceuticals Co., Ltd | 2022-01-20 |
| Lenvatinib and Pembrolizumab Maintenance Therapy for the Treatment of Patients of Advanced Unresectable Pancreatic Cancer (NCT04887805) | City of Hope Medical Center | 2021-07-21 |
| Study Of Gemcitabine, Nab-paclitaxel, PEGPH20 and Rivaroxaban for Advanced Pancreatic Adenocarcinoma (NCT02921022) | Memorial Sloan Kettering Cancer Center | 2016-10-01 |
Track Advanced Pancreatic Ductal Adenocarcinoma automatically
Every clearance here is in the API, with alerts when new ones post.